Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hectorol in Vitamin D-replete CKD with SHPT
NCT00123461Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in secondary hyperparathyroidism (SHPT) comparing Hectorol with Placebo (2 arms). Primary endpoint: intact parathyroid hormone at 6 months. Started Jul 2005; status: completed.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00123461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123461.